175 related articles for article (PubMed ID: 31505651)
1. Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization.
Lee J; Yoon JS; Kim JS; Koom WS; Cho J; Suh CO
Jpn J Clin Oncol; 2019 Jul; 49(7):664-670. PubMed ID: 31505651
[TBL] [Abstract][Full Text] [Related]
2. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity.
Goda JS; Le LW; Lapperriere NJ; Millar BA; Payne D; Gospodarowicz MK; Wells W; Hodgson DC; Sun A; Simpson R; Tsang RW
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e659-66. PubMed ID: 21640514
[TBL] [Abstract][Full Text] [Related]
3. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
[TBL] [Abstract][Full Text] [Related]
4. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior.
Suh CO; Shim SJ; Lee SW; Yang WI; Lee SY; Hahn JS
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):228-33. PubMed ID: 16503386
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of partial-orbit irradiation as a treatment strategy for patients with orbital mucosa-associated lymphoid tissue lymphoma.
Chung SY; Kook KH; Oh YT
Can J Ophthalmol; 2024 Jun; 59(3):e227-e232. PubMed ID: 37084769
[TBL] [Abstract][Full Text] [Related]
6. Primary radiotherapy for localized orbital MALT lymphoma.
Le QT; Eulau SM; George TI; Hildebrand R; Warnke RA; Donaldson SS; Hoppe RT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):657-63. PubMed ID: 11849787
[TBL] [Abstract][Full Text] [Related]
7. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes.
Harada K; Murakami N; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Sumi M; Suzuki S; Tobinai K; Uno T; Itami J
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):650-4. PubMed ID: 24521680
[TBL] [Abstract][Full Text] [Related]
8. Treatment effects and sequelae of radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma.
Hata M; Omura M; Koike I; Tomita N; Iijima Y; Tayama Y; Odagiri K; Minagawa Y; Ogino I; Inoue T
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1387-93. PubMed ID: 20950950
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma.
Fang P; Gunther JR; Pinnix CC; Dong W; Strati P; Nastoupil LJ; Steiner RE; Ahmed S; Damron EP; Fowler N; Nair R; Westin JR; Neelapu S; Ha CS; Dabaja BS
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1414-1420. PubMed ID: 33309978
[TBL] [Abstract][Full Text] [Related]
10. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes.
Fung CY; Tarbell NJ; Lucarelli MJ; Goldberg SI; Linggood RM; Harris NL; Ferry JA
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1382-91. PubMed ID: 14630277
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy for orbital lymphoma.
Zhou P; Ng AK; Silver B; Li S; Hua L; Mauch PM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):866-71. PubMed ID: 15925453
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma.
Tran KH; Campbell BA; Fua T; MacManus M; Ryan G; Chesson B; Wirth A
Leuk Lymphoma; 2013 Mar; 54(3):491-6. PubMed ID: 23020137
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy.
Parikh RR; Moskowitz BK; Maher E; Della Rocca D; Della Rocca R; Culliney B; Shapira I; Grossbard ML; Harrison LB; Hu K
Leuk Lymphoma; 2015 May; 56(5):1266-70. PubMed ID: 25356924
[TBL] [Abstract][Full Text] [Related]
14. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
Tsang RW; Gospodarowicz MK; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Patterson BJ
J Clin Oncol; 2003 Nov; 21(22):4157-64. PubMed ID: 14615444
[TBL] [Abstract][Full Text] [Related]
15. Recurrence patterns of mucose-associated lymphoid tissue lymphoma after definitive radiation treatment: A single center experience.
Joo JH; Lee SW; Huh J; Suh C; Yoon DH; Ahn SD; Choi EK; Kim JH
Hematology; 2016 Oct; 21(9):542-8. PubMed ID: 27168138
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma.
Nam H; Ahn YC; Kim YD; Ko Y; Kim WS
Radiother Oncol; 2009 Feb; 90(2):236-41. PubMed ID: 18950885
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy in the Management of Orbital Lymphoma: A Single Institution's Experience Over 4 Decades.
Kharod SM; Herman MP; Morris CG; Lightsey J; Mendenhall WM; Mendenhall NP
Am J Clin Oncol; 2018 Jan; 41(1):100-106. PubMed ID: 26398063
[TBL] [Abstract][Full Text] [Related]
18. Curative radiotherapy for primary orbital lymphoma.
Bhatia S; Paulino AC; Buatti JM; Mayr NA; Wen BC
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):818-23. PubMed ID: 12377334
[TBL] [Abstract][Full Text] [Related]
19. Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysis.
Eze C; Friedrich I; Hadi I; Schmidt-Hegemann NS; Hartoyo SN; Trauth R; Reitz D; Manapov F; Siefert A; Dreyling M; Belka C; Li M
Eur J Haematol; 2022 Jul; 109(1):21-30. PubMed ID: 35276022
[TBL] [Abstract][Full Text] [Related]
20. Ocular adnexal MALTomas: case series of patients treated with primary radiation.
Russell W; Herskovic A; Gessert D; Cohen JA; Rubenstein JB; Gregory SA
Clin Adv Hematol Oncol; 2013 Apr; 11(4):209-14. PubMed ID: 23604236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
